Epam Systems [EPAM] vs Accenture plc [ACN] Detailed Stock Comparison
Epam Systems
NYSE
Loading...
Accenture plc
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Epam Systems wins in 7 metrics, Accenture plc wins in 12 metrics, with 0 ties. Accenture plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Epam Systems | Accenture plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 23.93 | 20.34 | Accenture plc |
| Price-to-Book Ratio | 2.54 | 5.22 | Epam Systems |
| Debt-to-Equity Ratio | 4.44 | 25.88 | Epam Systems |
| PEG Ratio | -2.73 | 1.39 | Epam Systems |
| EV/EBITDA | 11.83 | 13.15 | Epam Systems |
| Profit Margin (TTM) | 7.91% | 11.61% | Accenture plc |
| Operating Margin (TTM) | 9.63% | 16.83% | Accenture plc |
| EBITDA Margin (TTM) | 9.63% | 16.83% | Accenture plc |
| Return on Equity | 11.35% | 26.93% | Accenture plc |
| Return on Assets (TTM) | 8.49% | 11.24% | Accenture plc |
| Free Cash Flow (TTM) | $527.02M | $8.61B | Accenture plc |
| Dividend Yield | N/A | 1.87% | N/A |
| 1-Year Return | -16.43% | -23.79% | Epam Systems |
| Price-to-Sales Ratio (TTM) | 1.84 | 2.33 | Epam Systems |
| Enterprise Value | $8.45B | $154.69B | Accenture plc |
| EV/Revenue Ratio | 1.67 | 2.26 | Epam Systems |
| Gross Profit Margin (TTM) | 28.77% | 32.87% | Accenture plc |
| Revenue per Share (TTM) | $89 | $109 | Accenture plc |
| Earnings per Share (Diluted) | $7.00 | $12.58 | Accenture plc |
| Beta (Stock Volatility) | 1.67 | 1.29 | Accenture plc |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Epam Systems vs Accenture plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Epam Systems | 5.19% | 4.46% | 0.54% | -9.37% | -20.32% | -27.39% |
| Accenture plc | 2.04% | 3.18% | -10.08% | -20.06% | -30.27% | -27.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Epam Systems | -16.43% | -60.62% | -49.00% | 131.59% | 1,091.98% | 1,091.98% |
| Accenture plc | -23.79% | -14.81% | 4.53% | 164.99% | 582.77% | 930.39% |
Performance & Financial Health Analysis: Epam Systems vs Accenture plc
| Metric | EPAM | ACN |
|---|---|---|
| Market Information | ||
| Market Cap | $9.33B | $159.38B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,011,380 | 5,082,600 |
| 90 Day Avg. Volume | 740,830 | 4,515,913 |
| Last Close | $175.03 | $259.18 |
| 52 Week Range | $138.15 - $269.00 | $236.67 - $398.35 |
| % from 52W High | -34.93% | -34.94% |
| All-Time High | $725.40 (Nov 01, 2021) | $417.37 (Dec 27, 2021) |
| % from All-Time High | -75.87% | -37.90% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.08% |
| Quarterly Earnings Growth | -0.11% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.12% |
| Operating Margin (TTM) | 0.10% | 0.17% |
| Return on Equity (TTM) | 0.11% | 0.27% |
| Debt to Equity (MRQ) | 4.44 | 25.88 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $65.85 | $49.07 |
| Cash per Share (MRQ) | $18.70 | $15.47 |
| Operating Cash Flow (TTM) | $449.58M | $10.95B |
| Levered Free Cash Flow (TTM) | $540.61M | $9.15B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.87% |
| Last 12-Month Dividend | N/A | $5.73 |
Valuation & Enterprise Metrics Analysis: Epam Systems vs Accenture plc
| Metric | EPAM | ACN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 23.93 | 20.34 |
| Forward P/E | 14.97 | 18.19 |
| PEG Ratio | -2.73 | 1.39 |
| Price to Sales (TTM) | 1.84 | 2.33 |
| Price to Book (MRQ) | 2.54 | 5.22 |
| Market Capitalization | ||
| Market Capitalization | $9.33B | $159.38B |
| Enterprise Value | $8.45B | $154.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.67 | 2.26 |
| Enterprise to EBITDA | 11.83 | 13.15 |
| Risk & Other Metrics | ||
| Beta | 1.67 | 1.29 |
| Book Value per Share (MRQ) | $65.85 | $49.07 |
Financial Statements Comparison: Epam Systems vs Accenture plc
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EPAM | ACN |
|---|---|---|
| Revenue/Sales | $1.30B | $17.73B |
| Cost of Goods Sold | $952.01M | $11.90B |
| Gross Profit | $349.68M | $5.83B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $99.33M | $2.98B |
| EBITDA | $151.42M | $3.31B |
| Pre-Tax Income | $94.42M | $2.95B |
| Income Tax | $20.94M | $707.18M |
| Net Income (Profit) | $73.48M | $2.24B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EPAM | ACN |
|---|---|---|
| Cash & Equivalents | $1.17B | $9.63B |
| Total Current Assets | $2.42B | $27.42B |
| Total Current Liabilities | $789.12M | $18.77B |
| Long-Term Debt | $118.67M | $7.33B |
| Total Shareholders Equity | $3.64B | $31.55B |
| Retained Earnings | $2.47B | $26.45B |
| Property, Plant & Equipment | $327.67M | $4.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EPAM | ACN |
|---|---|---|
| Operating Cash Flow | $82.27M | $2.96B |
| Capital Expenditures | $-9.33M | $-169.11M |
| Free Cash Flow | $14.83M | $3.52B |
| Debt Repayment | $-684,000 | $0 |
| Common Stock Repurchase | $-160.00M | $-1.80B |
Short Interest & Institutional Ownership Analysis
| Metric | EPAM | ACN |
|---|---|---|
| Shares Short | 1.73M | 12.40M |
| Short Ratio | 3.16 | 3.49 |
| Short % of Float | 0.04% | 0.02% |
| Average Daily Volume (10 Day) | 1,011,380 | 5,082,600 |
| Average Daily Volume (90 Day) | 740,830 | 4,515,913 |
| Shares Outstanding | 56.87M | 625.28M |
| Float Shares | 53.79M | 621.78M |
| % Held by Insiders | 0.04% | 0.00% |
| % Held by Institutions | 0.97% | 0.82% |
Dividend Analysis & Yield Comparison: Epam Systems vs Accenture plc
| Metric | EPAM | ACN |
|---|---|---|
| Last 12-Month Dividend | N/A | $5.73 |
| Last 12-Month Dividend Yield | N/A | 1.87% |
| 3-Year Avg Annual Dividend | N/A | $5.39 |
| 3-Year Avg Dividend Yield | N/A | 0.41% |
| 3-Year Total Dividends | N/A | $16.17 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |